PMP Archives - Bio-Me https://bio-me.com/tag/pmp/ Next generation microbiome profiling Thu, 07 Sep 2023 08:54:17 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 Bio-Me selected as a partner in the PREVALUNG EU program developing predictive biomarkers associated with lung cancer risk  https://bio-me.com/uncategorized/bio-me-selected-as-a-partner-in-the-prevalung-eu-program-developing-predictive-biomarkers-associated-with-lung-cancer-risk/ https://bio-me.com/uncategorized/bio-me-selected-as-a-partner-in-the-prevalung-eu-program-developing-predictive-biomarkers-associated-with-lung-cancer-risk/#respond Thu, 07 Sep 2023 08:52:22 +0000 https://bio-me.com/?p=4306 The PREVALUNG EU program aims to implement cancer risk stratification tools and personalized interventions to intercept lung cancer in cardiovascular patients. Bio-Me’s Precision Microbiome Profiling (PMP™) was chosen for high-throughput gut microbiome profiling. Read More

The post Bio-Me selected as a partner in the PREVALUNG EU program developing predictive biomarkers associated with lung cancer risk  appeared first on Bio-Me.

]]> https://bio-me.com/uncategorized/bio-me-selected-as-a-partner-in-the-prevalung-eu-program-developing-predictive-biomarkers-associated-with-lung-cancer-risk/feed/ 0 Bio-Me’s technology used for identifying bacteria associated with appendicular lean mass in a Nature Communications publication https://bio-me.com/uncategorized/bio-mes-technology-used-for-identifying-bacteria-associated-with-appendicular-lean-mass-in-a-nature-communications-publication/ https://bio-me.com/uncategorized/bio-mes-technology-used-for-identifying-bacteria-associated-with-appendicular-lean-mass-in-a-nature-communications-publication/#respond Thu, 27 Apr 2023 08:57:50 +0000 https://bio-me.com/?p=4288 PMP™ was used in a recent study to identify gut microbial species that are directly associated with appendicular lean mass and bone mineral density. More than 5000 fecal samples from the HUNT Biobank in Norway were analyzed with PMP™. Read More

The post Bio-Me’s technology used for identifying bacteria associated with appendicular lean mass in a Nature Communications publication appeared first on Bio-Me.

]]> https://bio-me.com/uncategorized/bio-mes-technology-used-for-identifying-bacteria-associated-with-appendicular-lean-mass-in-a-nature-communications-publication/feed/ 0 Bio-Me´s PMP™ platform demonstrates its diagnostic and prognostic applicability in pediatric IBD https://bio-me.com/uncategorized/bio-mes-pmp-platform-demonstrates-its-diagnostic-and-prognostic-applicability-in-pediatric-ibd/ https://bio-me.com/uncategorized/bio-mes-pmp-platform-demonstrates-its-diagnostic-and-prognostic-applicability-in-pediatric-ibd/#respond Fri, 05 Aug 2022 10:23:00 +0000 https://bio-me.com/?p=3884 PMP™ was used in a recent study to explore the gut microbiome of children with inflammatory bowel disease (IBD), symptomatic non-IBD, and healthy children. Diagnostic, Phenotype and Prognostic Indexes were constructed based on PMP™ data with very good discriminating properties. Read More

The post Bio-Me´s PMP™ platform demonstrates its diagnostic and prognostic applicability in pediatric IBD appeared first on Bio-Me.

]]> https://bio-me.com/uncategorized/bio-mes-pmp-platform-demonstrates-its-diagnostic-and-prognostic-applicability-in-pediatric-ibd/feed/ 0 Bio-Me´s technology demonstrates its usefulness in metabolic syndrome research in a Lancet publication https://bio-me.com/uncategorized/bio-mes-technology-demonstrates-its-usefulness-in-metabolic-syndrome-research-in-a-lancet-publication/ https://bio-me.com/uncategorized/bio-mes-technology-demonstrates-its-usefulness-in-metabolic-syndrome-research-in-a-lancet-publication/#respond Fri, 10 Jun 2022 06:02:33 +0000 https://bio-me.com/?p=3627 PMP™ has shown its applicability in obesity research in a study published in The Lancet. More than 5000 fecal samples from the HUNT Biobank in Norway were analyzed with PMP™. Read More

The post Bio-Me´s technology demonstrates its usefulness in metabolic syndrome research in a Lancet publication appeared first on Bio-Me.

]]> https://bio-me.com/uncategorized/bio-mes-technology-demonstrates-its-usefulness-in-metabolic-syndrome-research-in-a-lancet-publication/feed/ 0 Bio-Me receives 2 million Euro in public funding https://bio-me.com/uncategorized/bio-me-receives-2-million-euro-in-public-funding/ https://bio-me.com/uncategorized/bio-me-receives-2-million-euro-in-public-funding/#respond Thu, 23 Apr 2020 07:02:13 +0000 https://bio-me.com/?p=2177 Bio-Me has received 2 million Euro in grants and public support from The Research Council of Norway to develop a companion diagnostic test for immune checkpoint inhibitor cancer treatments.

Read More

The post Bio-Me receives 2 million Euro in public funding appeared first on Bio-Me.

]]> https://bio-me.com/uncategorized/bio-me-receives-2-million-euro-in-public-funding/feed/ 0